NCT00230789 Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication. Status COMPLETED Phase PHASE4
NCT00224146 Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder Status COMPLETED Phase PHASE4
NCT00196404 Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder Status COMPLETED Phase PHASE2
NCT00178282 Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence Status TERMINATED Phase NA
NCT00147654 Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction Status COMPLETED Phase PHASE4
NCT00143481 Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women Status COMPLETED Phase PHASE4
NCT00143377 Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB Status COMPLETED Phase PHASE4
NCT00139724 Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet Status COMPLETED Phase PHASE3
NCT00137397 A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder Status COMPLETED Phase PHASE4
NCT00127270 Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder Status COMPLETED Phase PHASE4
NCT00113555 Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence Status COMPLETED Phase NA
NCT00099372 Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse Status TERMINATED Phase N/A